Bringing Discoveries to Commercialization
ICBI Company Scioto Biosciences Closes $1.8M in Series A Financing, Receives Grants to Support Launch of New Microbiome Platform Technology

Events

ICBI Company Scioto Biosciences Closes $1.8M in Series A Financing, Receives Grants to Support Launch of New Microbiome Platform Technology

Monday, May 21, 2018

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology.

The funding represents a first-time interstate collaboration between two Indiana-based investors, BioCrossroads and Elevate Ventures, together with Ohio-based Rev1 Ventures, and follows a $330,000 Small Business Technology Transfer grant from the National Institute of Health (NIH) along with a $50,000 match from the State of Indiana.

Read more…